Avita Medical
RCEL
Operating Margin for Avita Medical (RCEL)
Operating Margin as of June 2024 (TTM): -77.36%
According to Avita Medical 's latest financial reports and stock price the company's current Operating Margin is -77.36%. At the end of 2021 the company had an Operating Margin of -90.73%.
Operating Margin history for Avita Medical from 2020 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -90.73% | -69.18% |
| 2020 | -294.42% | -35.74% |
| 2019 | -458.15% | -69.28% |
| 2018 | -1,491.28% | 40.33% |
| 2017 | -1,062.69% | -5.3% |
| 2016 | -1,122.13% | 297.63% |
| 2015 | -282.21% | 14.15% |
| 2014 | -247.23% | -15.34% |
| 2013 | -292.04% | 26.17% |
| 2012 | -231.47% | 286.49% |
| 2011 | -59.89% | -74.04% |
| 2010 | -230.69% | 11.43% |
| 2009 | -207.03% | -79.17% |
| 2008 | -993.99% | -13.51% |
| 2007 | -1,149.25% | 10.44% |
| 2006 | -1,040.57% | |
| 2004 | -1,278.53% | |
| 2002 | -774.79% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | 664.63% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | 66.75% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | 93.34% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | -51.50% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.